ÂÜÀòÂÒÂ×

Eric Bjerkholt is an accomplished financial executive currently serving as Chief Financial Officer at Mirum Pharmaceuticals, Inc. since September 2023. Bjerkholt brings extensive experience from previous roles as Chief Financial Officer at Chinook Therapeutics, Inc. and Aimmune Therapeutics, as well as significant leadership at Sunesis Pharmaceuticals and IntraBiotics. Prior to these positions, Bjerkholt held the role of EVP Finance and Strategy at LifeSpring Nutrition and contributed to JP Morgan as Vice President. Educational credentials include an MBA from Harvard Business School and a Master's degree in Economics from the University of Oslo.